Navigation Links
Synthetic Biologics Responds to Recent CDC Report on Threat of "Super Bugs"
Date:9/20/2013

ROCKVILLE, Md., Sept. 20, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, has issued a response to the recent report issued by the Centers for Disease Control and Prevention (CDC) earlier this week that detailed the growing threat of antibiotic-resistant "super bugs" (see here: Untreatable: Report by CDC details today's drug-resistant health threats).

(Logo: http://photos.prnewswire.com/prnh/20130522/MM19465LOGO )

Below is a statement from the Company:

"We applaud the CDC for taking the step forward in acknowledging the major public health crisis surrounding drug-resistant "super bugs." Among the CDC's top three, newly-ranked, drug-resistant bacteria, is Clostridium difficile (C. diff). C. diff is a deadly bacterium, with 94% of cases being associated with medical care settings. While treating an infection, IV antibiotics can wipe out the balance of a patient's microbiome, leaving them susceptible to life-threatening C. diff infections. If patients contract C. diff, they can spend an additional 4-7 days in the hospital1, costing the U.S. healthcare system in excess of $8 billion annually2. Of the 1.1 million patient's infected with C. diff in the hospital setting3, 30,000 die with a C. diff infection in the United States each year4.

Currently, there are no approved treatments designed to protect a patient's microbiome from the damaging effects of IV antibiotics, leaving patients highly exposed to what's been dubbed the "nightmare infection" in many hospitals. We view the recent ranking o
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Synthetic Biologics to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
2. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
3. Synthetic Biologics to Report Second Quarter 2013 Financial Results
4. Synthetic Biologics Initiates Manufacturing Process for C. difficile Infectious Disease Program
5. Synthetic DNA Deemed Patentable by US Supreme Court, Gene Synthesis and Codon Optimization Provide Potential Pathway to Patentability
6. Synthetic Biologics to Present at OneMedForum New York 2013
7. New England Biolabs supports iGEM synthetic biology competition
8. Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference
9. Intrexon Organizes Around New Synthetic Biology Markets
10. Intrexon Corporation Raises $150 Million for Synthetic Biology Initiatives
11. Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Trimb Healthcare AB ("Trimb") today announced that ... BV ("YouMedical"), a Dutch OTC company with operations in ... approximately EUR 16 million, with solid growth and leading ... is to build a leading international OTC company, and ... YouMedical gives us a stronger North European OTC platform, ...
(Date:8/30/2015)... England , August 31, 2015 ...   einer Frau   für chirurgische   Behandlung     ... von 7-90   werden für eine   verheerende ... 1200 Frauen behandeln und die Anzahl ausgebildeter Chirurgen in ... Astellas gab heute bekannt, dass  Action on Fistula ...
(Date:8/28/2015)... VANCOUVER , Aug. 28, 2015 /PRNewswire/ - ... clinical stage regenerative medicine company focused on the ... results for the quarter ended June 30, 2015, ... statements and management report are available at ... www.replicel.com . "RepliCel expects to ...
(Date:8/27/2015)...  Neogen Corporation (NASDAQ: NEOG ) announced today ... United Kingdom -based Lab M Holdings, a developer, ... systems. Lab M was founded in ... microbial testing and diagnostic products for the global food, ... sells into more than 70 countries worldwide, and has ...
Breaking Biology Technology:Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Neogen acquires U.K.-based Lab M Holdings 2
... PETACH TIKVA, Israel, August 16 Healthcare,Technologies Ltd. (NASDAQ: ... an,extraordinary general meeting of its shareholders to be held ... of Yigal Arnon & Co., 1 Azrieli,Center, Round Tower, ... shareholders will be asked to approve the previously,announced Asset ...
... Support for Vermed Sale, SAN DIEGO, Aug. 16 ... and leader of,impedance cardiography (ICG) technology, today announced that ... well with over 50%,of the necessary shareholder votes (approximately ... Vermed sale. The ratio of votes,received is running in ...
... affiliate of,Phlo Corporation (OTC: PHLC) (the "Company") announced ... now been expanded to the San,Francisco and Napa/Sonoma ... and stretching to the Oregon border. New ... Grocery in Palo Alto, Zanotto,s Grocery in Silicon ...
Cached Biology Technology:Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction 2Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction 3CardioDynamics Provides 2007 Shareholder Meeting Update 2CardioDynamics Provides 2007 Shareholder Meeting Update 3Phlo Affiliate Reports Expanded Coverage to Oregon Border 2
(Date:8/5/2015)... VIEW, Calif. , Aug. 5, 2015 ... exhibits continuous growth in applications, penetration into newer sectors, ... after year. The global biosensors space has seen the ... exited the market so far. (Photo - ... Frost & Sullivan, Analysis of the Global Biosensors ...
(Date:8/4/2015)...  AMRI (NASDAQ: AMRI ) today reported financial and operating ... Highlights: , Second quarter contract revenue of $ ... , Adjusted contract margins of 26 % ... $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial quarter, ...
(Date:7/31/2015)... SHENZHEN , Kina, 31. juli 2015 ... ) bliver afholdt af BGI fra den 22. - 25. ... Konferencen fejrer sin 10-års fødselsdag i år. ... verdens mest indflydelsesrige årlige møder på ,omik,-feltet, og er ... forsamlinger. ICG-10 fokuserer på nylige gennembrud ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... By coupling a kicked-up version of microscopy with miniscule particles ... so deep into living tissue that they can see molecules ... the researchers believe that their new approach can have a ... a tumor as it is removed from the body to ...
... Any way you slice it, the planarian,s contributions to biological ... a flatworm normally living in freshwater, is well known for ... into 200 pieces can generate 200 new individuals. New research ... master of regeneration, but can help scientists understand the basis ...
... mother of two to promote company,s highly secure, do ... yourself, smartTOUCH(R) finger activated products, JERICHO, ... today announced that it has hired Debbe Dunning as,the ... it,embarks upon an advertising campaign directed at the Home ...
Cached Biology News:New technique sees into tissue at greater depth, resolution 2New technique sees into tissue at greater depth, resolution 3'Home Improvement' Star Debbe Dunning is New smartTOUCH Spokesperson 2'Home Improvement' Star Debbe Dunning is New smartTOUCH Spokesperson 3
Mouse Anti-Human Kallikrein 2 (Hk2)...
... to Asb-2 (Ankyrin repeat and SOCS box-containing ... synthetic peptides containing amino acids 75-93 and ... lysate (Imgenex Catalog No. 40149) can be ... cross react with mouse and rat Asb-2, ...
Recognizes TWIK-2. Does not cross react with any other known proteins....
... Glycine Transporter 2, Neuronal (GLYT2). The ... from the central nervous system. The staining ... pattern described using in situ hybridization with ... has been described for glycinergic neurons. Preabsorption ...
Biology Products: